Cryo-Cell International
CCEL
12 hedge funds and large institutions have $5.04M invested in Cryo-Cell International in 2023 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 1 closing their positions.
101% more capital invested
Capital invested by funds: $2.5M → $5.04M (+$2.53M)
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
0.16% more ownership
Funds ownership: 9.83% → 9.98% (+0.16%)
0% more funds holding
Funds holding: 12 → 12 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$7.27K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$7.13K |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$252 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
-$17.3K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$535 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
HLA
1
Hamilton Lane Advisors
Conshohocken,
Pennsylvania
| $2.49M | – | – | – |
|
|
SA
2
SFI Advisors
Montclair,
New Jersey
| $1.01M | – | – | – |
|
|
MPWT
3
MassMutual Private Wealth & Trust
Windsor,
Connecticut
| $755K | – | – | – |
|
|
4
Vanguard Group
Malvern,
Pennsylvania
| $449K | +$7.13K | +1,475 | +2% |
|
5
Cerity Partners
New York
| $119K | – | – | – |
|
6
Geode Capital Management
Boston,
Massachusetts
| $116K | – | – | – |
|
|
7
BlackRock
New York
| $84.9K | +$7.27K | +1,503 | +12% |
|
8
Osaic Holdings
Scottsdale,
Arizona
| $15.2K | – | – | – |
|
9
Morgan Stanley
New York
| $2.43K | – | – | – |
|
|
TRCT
10
Tower Research Capital (TRC)
New York
| $517 | -$17.3K | -3,572 | -98% |
|
11
Wells Fargo
San Francisco,
California
| $152 | – | – | – |
|
|
12
UBS Group
Zurich,
Switzerland
| – | -$535 | -177 | Closed |
|
|
13
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | +$252 | +52 | New |
|
CCEL Hedge Fund Activity: Q2 2023 in Review
12 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Cryo-Cell International (CCEL) for Q2 2023, worth a combined $5.04M — up 101% from $2.5M a quarter earlier.
Fund positioning in CCEL was balanced in Q2 2023: 1 fund opened new positions, 1 closed out, 2 added to existing stakes and 1 trimmed.
The largest buyer was BlackRock, adding an estimated $7.27K. The largest seller was Tower Research Capital (TRC), cutting an estimated $17.3K.
- 12 institutional investors held Cryo-Cell International (CCEL) as of Q2 2023, unchanged from Q1 2023.
- Funds reported $5.04M of Cryo-Cell International stock for Q2 2023, up 101% quarter-over-quarter.
- 1 fund opened new Cryo-Cell International positions in Q2 2023 and 1 closed out, a net change of 0 holders.
- The largest Cryo-Cell International buyer in Q2 2023 was BlackRock, an estimated $7.27K added.
- The largest Cryo-Cell International seller in Q2 2023 was Tower Research Capital (TRC), an estimated $17.3K sold.
Based on aggregated 13F filings for Q2 2023.